Yoo Albert J, Andersson Tommy
Texas Stroke Institute, Dallas-Fort Worth, TX, USA.
Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden.
J Stroke. 2017 May;19(2):121-130. doi: 10.5853/jos.2017.00752. Epub 2017 May 31.
The overwhelming clinical benefit of intra-arterial stroke therapy owes to the major advance in revascularization brought on by the current generation of thrombectomy devices. Nevertheless, there remains a sizeable proportion of patients for whom substantial reperfusion cannot be achieved or is achieved too late. This article addresses the persistent challenges that face neurointerventionists and reviews technical refinements that may help to mitigate these obstacles to procedural success. Insights from in vitro modeling and clinical research are organized around a conceptual framework that examines the interaction between the device, the thrombus and the vessel wall.
动脉内卒中治疗的巨大临床益处归功于当前一代取栓装置在血管再通方面取得的重大进展。然而,仍有相当一部分患者无法实现实质性再灌注或再灌注时间过晚。本文探讨了神经介入医生面临的持续挑战,并回顾了可能有助于减轻这些手术成功障碍的技术改进。来自体外模型和临床研究的见解围绕一个概念框架进行组织,该框架审视了装置、血栓和血管壁之间的相互作用。